WO2002006839A3 - Blood group serological analysis method - Google Patents

Blood group serological analysis method Download PDF

Info

Publication number
WO2002006839A3
WO2002006839A3 PCT/EP2001/007928 EP0107928W WO0206839A3 WO 2002006839 A3 WO2002006839 A3 WO 2002006839A3 EP 0107928 W EP0107928 W EP 0107928W WO 0206839 A3 WO0206839 A3 WO 0206839A3
Authority
WO
WIPO (PCT)
Prior art keywords
analysis method
test preparation
blood group
erythrocytes
agglutination
Prior art date
Application number
PCT/EP2001/007928
Other languages
German (de)
French (fr)
Other versions
WO2002006839A2 (en
Inventor
Walter Ulm
Reiner Prochnow
Original Assignee
Olympus Diagnostica Gmbh
Walter Ulm
Reiner Prochnow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olympus Diagnostica Gmbh, Walter Ulm, Reiner Prochnow filed Critical Olympus Diagnostica Gmbh
Priority to AU2001285821A priority Critical patent/AU2001285821A1/en
Publication of WO2002006839A2 publication Critical patent/WO2002006839A2/en
Publication of WO2002006839A3 publication Critical patent/WO2002006839A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Abstract

According to a blood group serological analysis method, a liquid test preparation is produced by mixing a sample containing erythrocytes with a sample containing erythrocytic antibodies. The test preparation is incubated in defined conditions and after the incubation, an optical test is carried out for possible agglutination of the erythrocytes contained in the test preparation. Polyethylene-glycol (PEG) is used in the test preparation as an agglutination-reinforcing substance. The conditions selected are such that the PEG alone cannot trigger spontaneous agglutination of the erythrocytes.
PCT/EP2001/007928 2000-07-13 2001-07-10 Blood group serological analysis method WO2002006839A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001285821A AU2001285821A1 (en) 2000-07-13 2001-07-10 Blood group serological analysis method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10034496.8 2000-07-13
DE2000134496 DE10034496A1 (en) 2000-07-13 2000-07-13 Blood group serological examination procedure

Publications (2)

Publication Number Publication Date
WO2002006839A2 WO2002006839A2 (en) 2002-01-24
WO2002006839A3 true WO2002006839A3 (en) 2002-12-05

Family

ID=7649071

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007928 WO2002006839A2 (en) 2000-07-13 2001-07-10 Blood group serological analysis method

Country Status (3)

Country Link
AU (1) AU2001285821A1 (en)
DE (1) DE10034496A1 (en)
WO (1) WO2002006839A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59218958A (en) * 1983-05-27 1984-12-10 Ishizu Seiyaku Kk Reagent for detecting irregular antibody
WO1998012347A1 (en) * 1996-09-17 1998-03-26 Board Of Regents, The University Of Texas System Rh blood group antigen compositions and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3157601B2 (en) * 1992-04-27 2001-04-16 オリンパス光学工業株式会社 Automatic blood analyzer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59218958A (en) * 1983-05-27 1984-12-10 Ishizu Seiyaku Kk Reagent for detecting irregular antibody
WO1998012347A1 (en) * 1996-09-17 1998-03-26 Board Of Regents, The University Of Texas System Rh blood group antigen compositions and methods of use

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DE MAN A J ET AL: "EVALUATION OF THE POLYETHYLENE GLYCOL ANTIGLOBULIN TEST FOR DETECTION OF RED BLOOD CELL ANTIBODIES", VOX SANGUINIS, vol. 58, no. 3, 1990, pages 207 - 210, XP008007279, ISSN: 0042-9007 *
JEONG S T ET AL: "DECREASED AGGLUTINABILITY OF METHOXY-POLYETHYLENE GLYCOL ATTACHED RED BLOOD CELLS: SIGNIFICANCE AS A BLOOD SUBSTITUTE", ARTIFICIAL CELLS, BLOOD SUBSTITUTES, AND IMMOBILIZATION BIOTECHNOLOGY, MARCEL DEKKER INC, US, vol. 24, no. 5, 1996, pages 503 - 511, XP000673685, ISSN: 1073-1199 *
JIMENEZ MARCO M TERESA ET AL: "Evaluation of the polyethylene glycol antiglobulin test for detection and identification of red blood cell antibodies.", SANGRE (SARAGOSSA), vol. 43, no. 1, February 1998 (1998-02-01), pages 21 - 24, XP008007394, ISSN: 0036-4355 *
KNIGHT R C ET AL: "Detection of red cell antibodies: Current and future techniques.", BRITISH JOURNAL OF BIOMEDICAL SCIENCE, vol. 52, no. 4, 1995, pages 297 - 305, XP008007278, ISSN: 0967-4845 *
PATENT ABSTRACTS OF JAPAN vol. 009, no. 093 (P - 351) 23 April 1985 (1985-04-23) *

Also Published As

Publication number Publication date
WO2002006839A2 (en) 2002-01-24
DE10034496A1 (en) 2002-01-31
AU2001285821A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
AU7780981A (en) Analytical method using centrifugal force
SE8102558L (en) IMMUNOLOGICAL DETERMINATION METHOD
ES2009939A6 (en) Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans.
AU583737B2 (en) Process and reagent for the specific determination of fructosamine
EP1340730A4 (en) Ceramic optical components and production method therefor
US5030554A (en) Conservative whole blood sample preparation technique
WO2003005039A1 (en) Method of preparing solution for quantification, quantification method using solution for quantification, instrument for preparing solution for quantification and method of using the same
EP0402846A3 (en) Fluorescence polarization immunoassay for tetrahydrocannabinoids
WO2002006839A3 (en) Blood group serological analysis method
ES8500999A1 (en) Glucose oxidase immunohistochemical detection of antinuclear antibodies.
EP1176424A3 (en) Whole blood immunoassay
WO1998029726A3 (en) Method of detecting and determining the concentration of total troponin i in a biological sample
WO2003010513A1 (en) Solution density measuring method, sample cell used for the method, and solution density measuring device
EP0363090A3 (en) Diagnostic test kit and method for determination of chlamydial or gonococcal antigens using a microporous membrane
EP0404590A3 (en) Method of and reagent for the prevention of turbidity
RU2000128553A (en) IMMUNOLOGICAL ANALYSIS OF HUMAN MEDULAZINE AND DIAGNOSTICS OF MULTIPLE SCLEROSIS WITH ITS HELP
EP0260599A3 (en) Method and agent for detecting antibodies against human and animal retroviruses, especially t-lymphotropic viruses
CN109239357A (en) Type Ⅳ collagen chemiluminescence immune detection reagent kit and preparation method thereof and detection method
JPS6413460A (en) Immunoassay method using amphoteric surfactant
CA2327414A1 (en) Immunoassay of human medullasin and diagnosis of multiple sclerosis using the same
ES8206854A1 (en) Single test compositions for immunoassays and method for their preparation.
McArthur et al. Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against the HY antigen on murine sperm
JPS56132563A (en) Reagent for testing biological material and use thereof
JPS6479661A (en) Immunological analysis
CN105572364A (en) Making method and detection method of kit for detecting di-n-butyl phthalate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AU AZ BA BB BG BR BY CA CN CO CR CU CZ DM DZ EC EE GD GE HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LT LV MA MD MG MK MN MX MZ NO NZ PL RO RU SG SI SK TJ TM TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AU AZ BA BB BG BR BY CA CN CO CR CU CZ DM DZ EC EE GD GE HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LT LV MA MD MG MK MN MX MZ NO NZ PL RO RU SG SI SK TJ TM TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
ENP Entry into the national phase

Country of ref document: RU

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: JP